Quteba Ebrahem Selected Research

Quteba Ebrahem Research Topics

4	Choroidal Neovascularization 01/2013 - 04/2002
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2018 - 02/2013
3	Neoplasms (Cancer) 07/2014 - 04/2012
2	Hypoxia (Hypoxemia) 01/2012 - 12/2008
2	Macular Degeneration (Age-Related Maculopathy) 08/2011 - 09/2006
2	Corneal Neovascularization 08/2011 - 11/2006
2	Pathologic Neovascularization 01/2010 - 12/2008
1	Myeloid Leukemia (Leukemia, Myelocytic) 05/2014
1	Leukemia 05/2014
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 02/2013
1	Macular Edema 10/2010
1	Diabetic Retinopathy (Retinopathy, Diabetic) 10/2010
1	Hyperglycemia 10/2010
1	Inflammation (Inflammations) 01/2010
1	Hyperoxia 12/2008
1	Retinopathy of Prematurity (Retrolental Fibroplasia) 12/2008

4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2012 - 11/2006
2	Decitabine FDA Link 02/2013 - 10/2012
2	CytidineIBA 02/2013 - 10/2012
2	EnzymesIBA 02/2013 - 10/2012
2	Tissue Inhibitor of Metalloproteinase-3IBA 01/2013 - 08/2011
2	Proteins (Proteins, Gene)FDA Link 04/2012 - 09/2006
2	Matrix Metalloproteinases (MMPs)IBA 01/2010 - 04/2002
1	NucleophosminIBA 10/2018
1	GoldIBA 07/2014
1	Glutathione (Reduced Glutathione)IBA 07/2014
1	LigandsIBA 07/2014
1	Co-Repressor ProteinsIBA 05/2014
1	MethyltransferasesIBA 02/2013
1	DNA (Deoxyribonucleic Acid)IBA 02/2013
1	Cytarabine (Cytosar-U)FDA LinkGeneric 02/2013
1	Azacitidine (5 Azacytidine)FDA Link 02/2013
1	Peptides (Polypeptides)IBA 01/2013
1	TetrahydrouridineIBA 10/2012
1	Therapeutic UsesIBA 10/2012
1	Cytidine DeaminaseIBA 10/2012
1	Retinaldehyde (Retinal)IBA 10/2010
1	BetacellulinIBA 10/2010
1	Matrix Metalloproteinase InhibitorsIBA 01/2010
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 12/2008
1	Oxygen (Dioxygen)IBA 12/2008
1	Interleukin-6 (Interleukin 6)IBA 11/2006
1	AntibodiesIBA 11/2006
1	Steroid Receptors (Steroid Receptor)IBA 11/2006
1	Mifepristone (RU 486)FDA Link 11/2006
1	Angiogenesis InhibitorsIBA 04/2003